Do not lower the dose or extend the time between injections on your own
In fact, semaglutide is approved by the US FDA for use in chronic weight management in adults with a body mass index (BMI) of 30 or greater or in those with a BMI of 27 or greater and at least one weight-related condition
Less common side effects can be headaches, dizziness, and low blood sugar
When initiating Ozempic, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia
The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment
This naturally occurring compound helps convert fat into energy, making it ideal for those on a weight management journey